Bio-Rad Laboratories Inc (BIO)
278.08
-7.20
(-2.52%)
USD |
NYSE |
Apr 24, 16:00
278.08
0.00 (0.00%)
After-Hours: 16:39
Bio-Rad Laboratories Cash from Operations (Quarterly): 81.05M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 81.05M |
| September 30, 2023 | 97.71M |
| June 30, 2023 | 98.07M |
| March 31, 2023 | 98.12M |
| December 31, 2022 | 79.66M |
| September 30, 2022 | 11.03M |
| June 30, 2022 | 53.27M |
| March 31, 2022 | 50.49M |
| December 31, 2021 | 170.87M |
| September 30, 2021 | 230.36M |
| June 30, 2021 | 154.62M |
| March 31, 2021 | 113.61M |
| December 31, 2020 | 294.38M |
| September 30, 2020 | 135.66M |
| June 30, 2020 | 92.12M |
| March 31, 2020 | 62.81M |
| December 31, 2019 | 159.80M |
| September 30, 2019 | 99.75M |
| June 30, 2019 | 155.40M |
| March 31, 2019 | 42.94M |
| December 31, 2018 | 105.01M |
| September 30, 2018 | 62.28M |
| June 30, 2018 | 77.86M |
| March 31, 2018 | 40.35M |
| December 31, 2017 | 69.36M |
| Date | Value |
|---|---|
| September 30, 2017 | 28.48M |
| June 30, 2017 | 62.50M |
| March 31, 2017 | -56.20M |
| December 31, 2016 | 94.75M |
| September 30, 2016 | 51.61M |
| June 30, 2016 | 77.16M |
| March 31, 2016 | -7.448M |
| December 31, 2015 | 35.95M |
| September 30, 2015 | 82.28M |
| June 30, 2015 | 38.53M |
| March 31, 2015 | 29.45M |
| December 31, 2014 | 40.22M |
| September 30, 2014 | 90.65M |
| June 30, 2014 | 76.87M |
| March 31, 2014 | 65.57M |
| December 31, 2013 | 70.55M |
| September 30, 2013 | 54.83M |
| June 30, 2013 | 19.74M |
| March 31, 2013 | 24.02M |
| December 31, 2012 | 86.24M |
| September 30, 2012 | 71.34M |
| June 30, 2012 | 73.64M |
| March 31, 2012 | 35.26M |
| December 31, 2011 | 81.50M |
| September 30, 2011 | 51.16M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
11.03M
Minimum
Sep 2022
294.38M
Maximum
Dec 2020
117.83M
Average
98.12M
Median
Mar 2023
Cash from Operations (Quarterly) Benchmarks
| Agilent Technologies Inc | 485.00M |
| Bruker Corp | 205.50M |
| Azenta Inc | 26.43M |
| Harvard Bioscience Inc | 4.303M |
| Bionano Genomics Inc | -29.78M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 72.20M |
| Cash from Financing (Quarterly) | -200.62M |
| Free Cash Flow | 218.26M |
| Free Cash Flow Per Share (Quarterly) | 1.348 |
| Free Cash Flow to Equity (Quarterly) | 28.22M |
| Free Cash Flow to Firm (Quarterly) | 38.80M |
| Free Cash Flow Yield | 2.68% |